GLOVE manufacturer UG Healthcare Corporation has started work on a new manufacturing facility in Malaysia that will boost its production capacity by 1.2 billion pieces of gloves per annum. Read more at The Business Times.
GLOVE manufacturer UG Healthcare Corporation has started work on a new manufacturing facility in Malaysia that will boost its production capacity by 1.2 billion pieces of gloves per annum.
In filings to the Singapore Exchange on Tuesday, the group said it acquired the land for the facility through its acquisition of UG Engineering, a company incorporated for the purpose of buying the property. UG Engineering bought the property in January for RM5 million and remained dormant until UG Healthcare purchased both the subsidiary and property.
The property is a vacant leasehold industrial plot measuring approximately 17,233 square metres. It is located near UG Healthcare's two manufacturing plants in Seremban in the state of Negeri Sembilan, which the company said would boost its economies of scale. UG Healthcare executive director and finance director Lee Jun Yih said work has started on the new facility, which is expected to be completed by the end of June 2021.
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Wildfires rage in California as heat wave lingers across US WestThree large wildfires continued to burn in California as a record-breaking heat wave was set to linger across large swaths of the western United ...
Read more »
Wildfires rage in California as heatwave lingers across US WestThree large wildfires continued to burn in California as a record-breaking heat wave was set to linger across large swaths of the western United ...
Read more »
Australia's CSL agrees to manufacture two Covid-19 vaccine candidatesSYDNEY (REUTERS) - Pharmaceutical company CSL Ltd said on Monday (Sept 7) it had agreed to manufacture a Covid-19 vaccine being developed by AstraZeneca and Oxford University if trials prove successful, with doses for Australia expected by early 2021.. Read more at straitstimes.com.
Read more »
Australia's CSL agrees to manufacture two COVID-19 vaccine candidatesCANBERRA: Pharmaceutical company CSL said on Monday (Sep 7) it had agreed to manufacture a COVID-19 vaccine being developed by AstraZeneca and ...
Read more »
Quarz Capital ups stake in Sunningdale Tech, becomes substantial shareholderFUND manager Quarz Capital Asia is now deemed a substantial shareholder of Sunningdale Tech, with the purchase of 4,600 shares via a market transaction on Monday having bumped its shareholding to 5.001 per cent. Read more at The Business Times.
Read more »
Broker's take: DBS expects iFast's growth to outpace industry, ups target priceDBS Group Research has increased its target price for Singapore-based wealth management and brokerage platform iFast Corp to S$2.60 from S$2.35, and maintained its 'buy' call. Read more at The Business Times.
Read more »